Page last updated: 2024-09-04

21-fluoro-16-ethyl-19-norprogesterone and Breast Cancer

21-fluoro-16-ethyl-19-norprogesterone has been researched along with Breast Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Goeij, CC; Go, KG; Luurtsema, G; Nieweg, OE; Sluyser, M; Studeny, M; Vaalburg, W; Van der Ploeg, E; Verhagen, A; Visser, GM1
Jonson, SD; Welch, MJ1
Andriole, DP; Dehdashti, F; Griffeth, LK; Katzenellenbogen, JA; McGuire, AH; Pomper, MG; Siegel, BA; Van Brocklin, HF; Welch, MJ1

Reviews

1 review(s) available for 21-fluoro-16-ethyl-19-norprogesterone and Breast Cancer

ArticleYear
PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.
    The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1998, Volume: 42, Issue:1

    Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Estrogens; Female; Fluorine Radioisotopes; Humans; Ligands; Neoplasm Metastasis; Norprogesterones; Progestins; Radiopharmaceuticals; Rats; Receptors, Estrogen; Receptors, Progesterone; Sex Hormone-Binding Globulin; Structure-Activity Relationship; Tamoxifen; Tomography, Emission-Computed

1998

Other Studies

2 other study(ies) available for 21-fluoro-16-ethyl-19-norprogesterone and Breast Cancer

ArticleYear
Metabolism of a [18F]fluorine labeled progestin (21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone) in humans: a clue for future investigations.
    Nuclear medicine and biology, 1994, Volume: 21, Issue:7

    Topics: Animals; Biotransformation; Brain Neoplasms; Breast Neoplasms; Fluorine Radioisotopes; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Mammary Neoplasms, Experimental; Meningioma; Mice; Norprogesterones; Receptors, Estrogen; Receptors, Progesterone; Tomography, Emission-Computed

1994
Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:8

    Topics: Breast Neoplasms; Female; Fluorine Radioisotopes; Humans; Middle Aged; Norprogesterones; Receptors, Progesterone; Tomography, Emission-Computed

1991